CVS Health Corporation
CVS
$76.19
$2.012.71%
NYSE
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 2.80% | 3.87% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.80% | 3.87% | |||
| Cost of Revenue | 3.44% | 4.39% | |||
| Gross Profit | -1.53% | 0.52% | |||
| SG&A Expenses | 4.26% | 4.94% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.53% | 4.45% | |||
| Operating Income | -28.67% | -16.06% | |||
| Income Before Tax | 138.89% | -311.41% | |||
| Income Tax Expenses | -408.86% | -19.87% | |||
| Earnings from Continuing Operations | 173.26% | -493.88% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 33.33% | 87.50% | |||
| Net Income | 174.04% | -489.32% | |||
| EBIT | -28.67% | -16.06% | |||
| EBITDA | -18.87% | -12.21% | |||
| EPS Basic | 173.98% | -488.39% | |||
| Normalized Basic EPS | -36.67% | -12.52% | |||
| EPS Diluted | 173.08% | -491.55% | |||
| Normalized Diluted EPS | -37.46% | -12.24% | |||
| Average Basic Shares Outstanding | 0.08% | 0.24% | |||
| Average Diluted Shares Outstanding | 1.34% | -0.08% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 2.35% | -1.25% | |||